Home
>
National Drug Code (NDC)
>
Nexterone
Nexterone - 43066-150-10 - (amiodarone hydrochloride)
Drug Information of Nexterone
| Product NDC: | 43066-150 |
| Proprietary Name: | Nexterone |
| Non Proprietary Name: | amiodarone hydrochloride |
| Active Ingredient(s): | 150 mg/100mL & nbsp; amiodarone hydrochloride |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Nexterone
| Product NDC: | 43066-150 |
| Labeler Name: | Baxter Healthcare Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022325 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20111212 |
Package Information of Nexterone
| Package NDC: | 43066-150-10 |
| Package Description: | 100 mL in 1 BAG (43066-150-10) |
NDC Information of Nexterone
| NDC Code | 43066-150-10 |
| Proprietary Name | Nexterone |
| Package Description | 100 mL in 1 BAG (43066-150-10) |
| Product NDC | 43066-150 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | amiodarone hydrochloride |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20111212 |
| Marketing Category Name | NDA |
| Labeler Name | Baxter Healthcare Corporation |
| Substance Name | AMIODARONE HYDROCHLORIDE |
| Strength Number | 150 |
| Strength Unit | mg/100mL |
| Pharmaceutical Classes | Antiarrhythmic [EPC] |
